AGC
TMO icon

Aspen Grove Capital’s Thermo Fisher Scientific TMO Stock Holding History

Aspen Grove Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Buy
516
+18
+4% +$8.64K 0.04% 178
2026
Q1 		$245K Sell
498
-6
-1% -$3.26K 0.05% 166
2025
Q4 		$292K Buy
504
+10
+2% +$5.66K 0.05% 147
2025
Q3 		$240K Sell
494
-6
-1% -$2.79K 0.04% 171
2025
Q2 		$203K Buy
+500
New +$209K 0.03% 223
2024
Q4 		– Sell
-406
Closed -$251K – 216
2024
Q3 		$251K Sell
406
-485
-54% -$287K 0.06% 166
2024
Q2 		$493K Buy
891
+66
+8% +$37.8K 0.12% 103
2024
Q1 		$480K Buy
825
+3
+0.4% +$1.68K 0.14% 97
2023
Q4 		$421K Sell
822
-166
-17% -$80.3K 0.13% 97
2023
Q3 		$500K Sell
988
-40
-4% -$21.3K 0.19% 84
2023
Q2 		$537K Sell
1,028
-165
-14% -$89K 0.17% 108
2023
Q1 		$688K Buy
1,193
+115
+11% +$64.8K 0.3% 70
2022
Q4 		$594K Buy
+1,078
New +$571K 0.27% 70

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Aspen Grove Capital's TMO Position: Q2 2026 in Review

Aspen Grove Capital increased its Thermo Fisher Scientific (TMO) stake by 3.6% in Q2 2026, buying an estimated $8.64K and bringing the position to 516 shares worth $259K. The position accounts for 0.04% of the portfolio, ranked #178.

Aspen Grove Capital first reported a position in TMO in Q4 2022 and has held it in 13 quarters since. The position peaked at $688K in Q1 2023. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Aspen Grove Capital held 516 shares of Thermo Fisher Scientific worth $259K as of Q2 2026.
  • Aspen Grove Capital bought 18 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.64K.
  • Thermo Fisher Scientific made up 0.04% of Aspen Grove Capital's portfolio in Q2 2026, its #178 holding.
  • Aspen Grove Capital first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 13 quarters since.
  • Aspen Grove Capital's Thermo Fisher Scientific position peaked at $688K in Q1 2023.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.